NCT02431806 Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02427789 Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major Depression Status COMPLETED Phase NA
NCT02422303 Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms Status TERMINATED Phase NA
NCT02421965 Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness Status COMPLETED Phase NA
NCT02418195 miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome Status COMPLETED Phase PHASE2
NCT02409823 Clinical Registry of Patients Under Treatment With Atypical Antipsychotics Status COMPLETED Phase N/A
NCT02407704 A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise Status COMPLETED Phase PHASE4
NCT02398877 HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms Status COMPLETED Phase NA
NCT02395978 A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT02389816 A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02385786 Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of Treatment Status COMPLETED Phase NA
NCT02383693 Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study Status UNKNOWN Phase PHASE2/PHASE3
NCT02378714 Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers Status COMPLETED Phase PHASE4
NCT02376257 Improving Therapeutic Learning in Depression: Proof of Concept Status COMPLETED Phase PHASE2
NCT02375308 Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression Status COMPLETED Phase NA
NCT02372799 Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Status COMPLETED Phase PHASE3